1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with dapsone in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (dapsone) | Trials (dapsone) | Recent Studies (post-2010) (dapsone) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 5,116 | 379 | 862 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | dapsone (IC50) |
---|---|---|---|
Myeloperoxidase | Homo sapiens (human) | 0.42 | |
Dihydrofolate reductase | Pneumocystis carinii | 1.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Modschiedler, K; von den Driesch, P; Weller, M; Wörl, P | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and dapsone
Article | Year |
---|---|
Dapsone and colchicine inhibit adhesion of neutrophilic granulocytes to epidermal sections.
Topics: Cell Adhesion; Colchicine; Dapsone; Epidermis; Flow Cytometry; Frozen Sections; Humans; Interferon-gamma; Macrophage-1 Antigen; Neutrophils; Platelet Activating Factor | 2000 |